In a national health survey of 1,057 Czech adults, nearly three in four people between 25 and 64 were found to have abnormal blood lipids, a quiet condition that rarely announces itself. Published in Nature's Scientific Reports, the study reminds us that in a country where cardiovascular disease remains the leading cause of death, the hidden burden of cholesterol and related fats is shared by many, yet recognized by few. Its finding is less a verdict than a mirror: between the ordinary act of noticing a problem and the harder work of bringing it under control, a great many people are falling t
Most Czech Adults with Dyslipidemia Unaware or Untreated, Study Finds
Only 23.7% of treated participants reached normal lipid values
Mark
Start with the headline number. Seventy-one point seven percent with dyslipidemia. That sounds enormous.
Mimi
It is, and it's the most common risk factor they measured among 1,057 adults aged 25 to 64. Over half had risk-level total cholesterol, 54.3%, and LDL was 52.3%.
Luke
Worth noting that the study uses its own defined thresholds. The 71.7% depends on how dyslipidemia was defined here, so it may not match figures from other surveys.
Mark
What about awareness?
Mimi
Only 33.4% of those with dyslipidemia knew they had it. So two in three were unaware.
Mark
And treatment?
Mimi
27.7% were aware and on lipid-lowering drugs. Then among the treated, only 23.7% hit the normal values.
Luke
Be careful with that last one. It says treated people often miss targets, but the summary doesn't tell us why. Dose, adherence, drug choice, how long they'd been treated: none of that is established here.
Mark
So what can we say confidently?
Mimi
That detection and control both look weak in this sample, in a country where cardiovascular disease is the leading cause of death.
Luke
And that it's a cross-sectional snapshot from 2019. It can't tell us whether things are improving or worsening.
O Pulso
- Nearly three in four Czech adults aged 25 to 64 carry abnormal blood lipids, making dyslipidemia the most widespread cardiovascular risk factor in the survey.
- Only about a third of those affected even know they have the condition, so a silent threat runs largely unnoticed.
- Among people who are treated, just under a quarter reach normal lipid values, exposing a stubborn gap between prescribing and results.
- Cardiovascular disease remains Czechia's leading cause of death, lending urgency to every missed detection and every unmet target.
- Researchers point to both detection and therapy as weak points, and the path forward depends on closing those gaps.
In a national health survey of 1,057 Czech adults, nearly three in four people between 25 and 64 were found to have abnormal blood lipids, a quiet condition that rarely announces itself. Published in Nature's Scientific Reports, the study reminds us that in a country where cardiovascular disease remains the leading cause of death, the hidden burden of cholesterol and related fats is shared by many, yet recognized by few. Its finding is less a verdict than a mirror: between the ordinary act of noticing a problem and the harder work of bringing it under control, a great many people are falling through.
Of the 1,057 Czech adults examined in a national health survey, just under three in four had abnormal blood lipids. For people aged 25 to 64, that is 71.7%, making dyslipidemia the most common cardiovascular risk factor the researchers measured. The finding appears in a study published in Scientific Reports, part of Nature's family of journals.
The context is sobering. Cardiovascular disease is still the leading cause of death in Czechia, and the authors link that burden to the persistently high prevalence of several risk factors, dyslipidemia chief among them. Their goal was practical: to learn how often people actually reach the lipid levels considered normal.
The researchers drew on the Czech portion of the 2019 European Health Examination Survey, a carefully sampled, standardized look at the population. The sample included 426 men and 631 women. Individual markers told part of the story: total cholesterol was at a risk level in 54.3% of participants and LDL cholesterol in 52.3%.
The sharper gaps came after detection. Only 33.4% of those with dyslipidemia knew they had it. Treatment did not reliably bring control either. Among those being treated, just 23.7% reached normal lipid values. The authors conclude that the problem lies in two places at once: people often do not know they are affected, and when they do, therapy often falls short of its target.
Of the 1,057 Czech adults examined in a national health survey, just under three in four had abnormal blood lipids. That figure, 71.7% of people aged 25 to 64, makes dyslipidemia the most common cardiovascular risk factor the researchers measured, and it sits at the center of a study published in Nature's Scientific Reports family.
The backdrop is a grim one. Cardiovascular diseases remain the leading cause of death in Czechia, and the authors tie that to the persistently high prevalence of several risk factors, dyslipidemia among them. Their aim was narrow and practical: to establish how often people actually reach the lipid control the study defined as normal.
They drew on the Czech arm of EHES 2019, the European Health Examination Survey. It is a cross-sectional epidemiological study built on stratified random sampling, with all parameters assessed under standardized criteria. The analysis used descriptive statistics and group comparisons. The sample included 426 men and 631 women.
The breakdown of individual lipid markers shows where the trouble lies. Total cholesterol was at a risk value in 54.3% of participants, and LDL cholesterol in 52.3%. Non-HDL cholesterol was elevated in 41.1%, triglycerides in 27.6%, and HDL cholesterol in 8.7%.
The larger gaps appear after detection. Among participants with dyslipidemia, only 33.4% were aware they had it. Those who knew about the condition and were taking lipid-lowering drugs made up 27.7% of the respondents the study counted in that group.
Treatment, in turn, did not reliably translate into control. Among treated participants, measured lipid levels met the study-defined normal values in only 23.7%. The authors conclude that the findings reveal both low patient awareness of the condition and low effectiveness in reaching lipid goals.
The numbers point to two separate weak points: finding the problem, and then managing it once found. Given that cardiovascular disease is the country's leading killer, the study frames both as places where detection and therapy fall short.
Citações Notáveis
The study revealed low patient awareness of their conditions and low efficacy in achieving lipid goals.— Study authors, EHES 2019 analysis
Quer a matéria completa?
Leia o original em Nature ↗
Business